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Abstract: One main limitation of established neuroimaging methods is the inability to directly visualize
large-scale neural dynamics in whole mammalian brains at subsecond speeds. Optoacoustic imaging
has advanced in recent years to provide unique advantages for real-time deep-tissue observations,
which have been exploited for three-dimensional imaging of both cerebral hemodynamic parameters
and direct calcium activity in rodents. Due to a lack of suitable calcium indicators excitable in
the near-infrared window, optoacoustic imaging of neuronal activity at deep-seated areas of the
mammalian brain has been impeded by the strong absorption of blood in the visible range of the light
spectrum. To overcome this, we have developed and validated an intracardially perfused mouse brain
preparation labelled with genetically encoded calcium indicator GCaMP6f that closely resembles
in vivo conditions. By overcoming the limitations of hemoglobin-based light absorption, this new
technique was used to observe stimulus-evoked calcium dynamics in the brain at penetration depths
and spatio-temporal resolution scales not attainable with existing neuroimaging techniques.
Keywords: optoacoustic neuroimaging; GCaMP6f; calcium dynamics; functional neuroimaging
1. Introduction
The mammalian brain is highly interconnected [1,2], comprised of specialized neuronal sub-circuits
that link together into a larger, functional network [2]. Information transmission and processing within
the nervous system occurs through simultaneous, parallel neuronal activity across a multitude of
different brain areas. Mapping neuronal activation with high spatio-temporal resolution across major
portions of the intact brain, including deep and hard-to-access areas, has been one of the long-term
goals of neuroscience, and could help discern its fundamental operating principles. To this end,
an array of imaging techniques is in development to allow non-invasive investigation of the brain’s
circuitry and network functionality.
Among the established methods of functional whole-brain imaging, blood oxygen-level dependent
functional magnetic resonance imaging (BOLD fMRI) is the most well-known. This approach is able to
detect blood oxygenation changes and blood flow in the brain [3]. Cerebral hemodynamic changes are
similarly linked to neural activity via neurovascular coupling [4] and thus BOLD fMRI has been used
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to make a number of observations regarding brain activity. The biggest drawback of this method is that
it can only indirectly access neuronal function. An important variant, Pharmacological MRI [5] allows
the study of vasoactive neurotransmitter dynamics by targeting specific receptors or neurotransmitters
chemically, but similarly lacks temporal resolution to resolve fast neuronal events, providing only
an indirect link between observed signal changes and the cellular and physiological mechanisms
underlying them [6]. Electroencephalography (EEG), another well-established method, is able to
measure voltage fluctuations induced by ionic currents within neurons at millisecond-range temporal
resolutions [7,8]. However, EEG suffers from poor spatial resolution in its ability to infer underlying
neural sources by solving an ill-posed inverse problem [9]. In similar fashion, magnetoencephalography
(MEG) can record the magnetic induction generated by electrochemical currents between and within
neurons, combining the high temporal resolution of EEG with an improved spatial resolution and
less distortion by modeling approximations [10]. The high acquisition and maintenance cost of MEG
systems, especially the need for magnetically shielded rooms to eliminate electromagnetic noise sources,
together with challenges in signal extraction and interpretation, make the method less suitable for
small animal neuroimaging.
A multitude of optical imaging methods have also emerged over the years as alternative approaches
for observing large neuronal populations [11], from macroscopic optical imaging techniques like
diffuse optical tomography [12] to several fluorescence microscopy methods based on voltage and
calcium indicators for direct neuronal activity mapping [13]. Recent two-photon microscopy systems
can visualize a large number of neurons across several cortical layers [14]. However, only cortical
layers can typically be imaged by those methods due to strong photon scattering by brain tissues.
Newly introduced three-photon systems can capture both cortical layers and the Stratum pyramidale
(SP) layer of the CA1 hippocampal region by utilizing infrared excitation wavelengths, but strongly
compromise their acquisition pixel rate and struggle to resolve structures beyond 1.1 mm of depth [15].
Several optical imaging strategies have been introduced to visualize deep brain structures beyond
this limit, such as the removal of overlying cortical tissues [16] and the insertion of fiber bundles [17],
graded index lenses [18], or minimally invasive multimode fibers [19]. However, the effective field
of view (FOV) remains well below 1 mm3 when attempting to resolve fast neuronal activity at high
volumetric frame rates [15,20]. Another caveat of optical brain microscopy approaches is the general
requirement for invasive procedures such as scalp and/or skull removal, the insertion of fibers, or the
implantation of lenses. Additionally, the installment of cranial windows is often necessary.
In recent years, optoacoustic (OA) tomography has proven to be a powerful alternative for imaging
optical absorption in highly scattering tissues such as the brain. In general, snapshots of large tissue
volumes can be recorded instantaneously as just a single laser pulse suffices to induce an OA response
in the entire volume of interest [21]. By relying on ultrasound detection of light-induced signals, the OA
approach overcomes the limitations of pure optical imaging systems in terms of penetration depth.
In this way, non-invasive, highly-specific molecular imaging is possible at depths where conventional
optical methods fail, up to a few centimeters in biological tissues [21,22]. Through the use of high-end
data acquisition systems and graphic-processing-unit (GPU)-based image rendering, non-invasive
acquisition, processing and visualization of five-dimensional OA data in real time has recently become
possible [21,23]. Functional brain imaging can be achieved by utilizing real-time volumetric spectrally
enriched tomography recordings [24]. Due to the strong and spectrally distinctive OA contrast
provided by deoxygenated and oxygenated hemoglobin, OA brain imaging has mainly focused on
blood oxygenation variations and hemodynamics [25], e.g., in order to observe stimulus-induced
brain function [26] and seizure activity in mice [23]. However, changes in hemodynamics only reflect
neuronal activity indirectly. In contrast, genetically encoded calcium indicators (GECIs) are a potent
tool for the direct observation of rapid neuronal activity of large brain networks. Using GECIs from
the GCaMP-family [27], we have recently shown that functional OA neuro-tomography (FONT) can
image fast calcium dynamics in the brains of zebra fish [21] and mice [28]. Yet, since GCaMP excitation
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is performed at its peak absorption wavelength of 488 nm, the strong absorption of light in this spectral
range by blood precludes visualization beyond the cortical areas in mammalian brains.
To demonstrate the fundamental capacity for calcium imaging in deep regions of the rodent
brain using FONT, we developed and validated here a GCaMP6f-expressing in situ mouse brain
model intracardially perfused with artificial cerebrospinal fluid that overcomes the limitations of
low penetration at visible wavelengths. This preparation is shown to resemble in vivo conditions,
demonstrating high viability and functional activity for more than 45 minutes while preserving
realistic indicator responses. Following the removal of highly absorbing blood background, large-scale
OA recording from mouse brains through skull and skin is implemented at penetration depths and
spatio-temporal resolution scales not possible with other existing neuroimaging techniques.
2. Materials and Methods
2.1. Perfused Mouse Model Preparation
A total of 8 mice ranging in age from eight- to twelve-weeks-old C57BL/6J-Tg (Thy1-GCaMP6f)
GP5.5Dkim/J (The Jackson Laboratory, Maine, ME, USA; stock number 024276) were used for these
experiments in full compliance with the institutional guidelines of the Institute for Biological and
Medical Imaging along with approval from the Government District of Upper Bavaria.
For cardiac perfusion, freshly prepared artificial cerebrospinal fluid (ACSF) [29] was continuously
supplied with Carbogen (Linde Group, Munich, Germany) and remained in a water bath (ThermoFisher
Scientific, Waltham, MA, USA) at 42 ◦C. Using a perfusion pump (Cole-Parmer, Vernon Hills, IL, USA),
ACSF was circulated at a rate of 6–8 ml/min through a glass heating coil (Radnoti LTD, Dublin, Ireland).
The flow continued through a bubble trap and a physiological pressure transducer (AD Instruments,
Sydney, Australia) connected to a pressure transducer Simulator/Tester (Utah Medical Products,
Midvale, UT, USA) and a 25G butterfly infusion set. ACSF was pumped through the setup for at least
2 min to ensure no bubbles remained.
Mice were anaesthetized with a mixture of 87.5 mg/kg Ketamine (Bremer Pharma, Wabing,
Germany) and 12.5 mg/kg Xylazine (Bela-pharm, Vechta, Germany) and additionally given 75 U
of Heparin (Ratiofarm GbmH, Ulm, Germany) diluted in 100 µl 0.9% NaCl Solution (Braun AG,
Melsungen, Germany), both administered via intraperitoneal (IP) injection. Once the mice reached a
stable plane of deep anesthesia as determined by the absence of a toe-pitch reflex at both hind paws,
the fur on top of the mouse head was removed using hair-removal cream. Animals were placed onto a
3.8 mm thick silicon sheet as seen in Figure 1a, with the head positioned above an opening covering
the field of view (FOV) of the FONT imaging system.
The silicon sheet was attached to a 4◦-sloped holder that additionally supported the spherical
transducer array used for capturing the FONT data. To avoid motion artefacts during all experiments,
the mouse head was fixed into a custom designed stereotactic mouse head holder (Narishige
International Limited, London, UK). At this stage, mice were injected with a second, lethal dose of
87.5 mg/kg Ketamine and 12.5 mg/kg Xylazine. After a second toe-pinch reflex test of the hind paws,
all extremities were secured with 25G needles by pinning onto the silicon sheet. Surgery began with an
incision from the mid abdomen to the sternum followed by removing the ventral portion of the ribcage
to allow unhindered access to the heart. Once the mouse heart stopped beating, intracardiac perfusion
with ACSF was performed by inserting the 25G butterfly needle into the left ventricle of the heart
followed by an incision into the right atrium. Pump speed was adjusted to ensure the pressure recorded
by the transducer did not exceed the physiological maximum of 100 mmHg. Fresh, oxygenated ACSF
was supplied during the entire duration of the experiment to preserve brain functionality and serve
as a vehicle for delivering the epileptic drug Pentylenetetrazol (PTZ). This convulsant significantly
blocks GABAA receptor function [30] and can induce seizures and thus widespread brain activity when
given in sufficient concentration [31,32]. PTZ (100 mg/ml in saline) could be added to the ACSF flow
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through a stopcock (Braun, Melsungen, Germany) connected to an Aladdin programmable syringe
pump (World Precision instruments, Sarasota, FL, USA).
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Figure 1. Imaging system design and baseline brain images (a) Layout of the experimental functional
optoacoustic neuro-tomography (FONT) setup used to record the blood clearing procedure. ACSF:
artificial cerebrospinal fluid; HC: heating coil; PT: pressure transducer; STA: spherical transducer array;
OPO: optical parametric oscillator; DAQ: data acquisition unit; PC: personal computer (b) Maximum
intensity projections (MIPs) of volumetric FONT images of a GCaMP6f-labeled brain before clearing.
A schematic of the perfusion and imaging setup is depicted in Figure 1a. Note that intracardiac
perfusion was selected as the vehicle of ACSF to provide consistent clearing results. Other methods of
ACSF delivery, such as perfusion through the tail vein with an incision of the external jugular vein
to serve as an outlet were explored, but deemed too unreliable for proper visualization of the brain.
By pumping oxygenated ACSF at 37.5 ◦C (when delivered through the heart) physiological conditions
for the blood-free brain could be established. Fixating the animals onto the silicon pad in combination
with the use of a head holder was necessary to avoid motion artifacts during recording, especially
random spasms induced by the addition of PTZ to the perfusion mix. The spherical array transducer
holder was designed with a 4◦ incline to allow easier collection of blood and ACSF flowing through
the incision in the right atrium and reduce the chance of contaminating the coupling medium. The use
of a pressure transducer improved the clearing efficiency during perfusion and reduced the amount of
vessels retaining blood when pressures did not exceed the physiological limit of 100 mmHg.
2.2. Electroencephalography Recordings
For electroencephalography (EEG) recordings, a GCaMP6f mouse (n = 1) was anaesthetized with
a Ketamine/Xylazine-mixture and administered Heparin as described above. Once the mouse reached
a stable level of anesthesia, the scalp was removed and a droplet of Xylonest 2% topical anesthetic
(AstraZeneca, Cambridge, UK) was applied to prevent excessive bleeding. Two small openings, one
in each hemisphere and set 5 mm apart, were cut into the mouse skull using a micro drill system
(CircuitMedic, Haverhill, MA, USA). The animal was then placed on the STR holder and fixed in
place using 25G needles. The head of the mouse was secured via a head holder. EEG-signals were
recorded via two custom-made needle electrodes fixed 5 mm apart to a micromanipulator (Narishige
International Limited, London, UK) and inserted into the openings drilled on the skull. Both electrodes
were connected to a to a DP-311 differential amplifier (Warner Instruments, Hamden, CT, USA) set to
a high pass of 10 Hz, a low pass of 100 Hz and a gain of 100. Amplified signals were digitized via
a PowerLab26T data acquisition module (AD Instruments, Sydney, Australia) controlled through a
host PC running the Labchart 8 software (AD Instruments, Sydney, Australia). A grounding electrode
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connected to the Powerlab DAQ was inserted into the skin around the neck of the mouse. After 10 min
of baseline recording, a lethal dose of Ketamine/Xylazine-mixture was administered via IP injection and
intracardiac perfusion was started as described above. To validate the responsiveness of the brain, 3 mL
of PTZ was injected into the perfusion setup over the course of 60 s. The recorded EEG signals were
processed using MatLab (Math Works, Natick, MA, USA) to compare the anesthetized and perfused
states and to identify periods of elevated brain activity following PTZ injection. For this, the EEG
spectrogram was calculated as the short-time Fourier transform with a window of 20 s, sufficient for
detecting higher frequency components in the 10–20 Hz range corresponding to seizure-like activity
caused by PTZ.
2.3. Fluorescence Recordings
Wide-field surface imaging of GCaMP6f fluorescence were performed during perfusion and PTZ
stimulation by means of a Luca R 604 high speed EMCCD camera (Andor Technology, Belfast, UK).
The camera was equipped with a 105 mm Nikon F mount objective (Nikon, Chiyoda, Tokio, Japan) and
a one-inch emission filter with 525 nm center wavelength and 39 nm bandwidth (MF525-39, Thorlabs
Inc., Newton, MA, USA). The illumination source was an optical parametric oscillator (OPO)-based
laser (EVO I OPO 355nm broadband, Innolas GmbH, Krailling, Germany) providing short (<10 ns)
pulses at 25 Hz with output wavelength set to 488 nm. The acquisition time of the camera was set to
200 ms, corresponding to the integration of five laser pulses.
A GCaMP6f mouse (n = 1) was anaesthetized, shaved and fixed in place on the silicon layer as
described above. The camera position was manually adjusted until the mouse head was in focus.
A single custom-made silica fused-end fiber bundle (CeramOptics GmbH, Bonn, Germany), positioned
below the mouse head and outside of the FOV of the camera, was used to illuminate the imaged area
from a single direction. The perfusion procedure was then continued, with the camera recording both
the clearing of blood and the subsequent injection of 3 ml PTZ over the course of 60 s. The relative
fluorescence signal changes (∆F/F0) were calculated from the recorded images as changes in signal
intensity following PTZ injection. These changes correspond to calcium responses evoked by neural
activity. The baseline fluorescence signal level F0 was calculated as the average of frames over 10 s
preceding the injection.
2.4. Functional Optoacoustic Neuro-Tomography (FONT) Recordings
The FONT imaging set-up consisted of a custom-made matrix transducer array (Imasonic SaS,
Voray, France) having 512 individual piezocomposite elements densely distributed over a 40 mm
radius spherical aperture covering an angle of 140◦ (1.31p solid angle). Each element has 2.5 mm
diameter, 5 MHz central frequency and ~100% -6dB bandwidth, thus the array provides an almost
isotropic resolution of 150–250 µm over an effective FOV of ~2 cm3 [33]. The 512 OA signals detected
by the array elements were simultaneously digitized with a custom-made data acquisition unit (DAQ,
Falkenstein Microsysteme, Taufkirchen, Germany) triggered with the Q-switch output of the tunable
OPO laser used for the excitation of OA responses. The digitized signals were transferred to a PC
via 1 Gbit/s Ethernet for further processing. The spherical matrix array transducer was placed into
the holder at a distance of ~1 cm from the bottom of the silicon sheet as seen in Figure 1a, where a
fiber bundle guided the illumination beam through a central cylindrical aperture. The bundle was
connected to the output of the OPO laser, which was set to emit alternating pulses of 488 nm/650 nm
light at 20 Hz repetition rate. GCaMP excitation was performed at 488 nm wavelength, while 650 nm
served as a control wavelength for which hemoglobin has significantly less optical absorption with
GCaMP having no residual absorption. The outer rim of the array transducer was sealed with 1.5%
Agar (Sigma-Aldrich, Taufkirchen, Germany) to prevent leakage, and the space between the silicone
sheet and the transducer’s active surface was filled with water to provide acoustic coupling for the
optoacoustically-generated ultrasound waves. GCaMP6f mice (n = 3) were perfused as described
Photonics 2019, 6, 67 6 of 15
above, and OA data was collected both during the blood clearing procedure and the PTZ-induced
neural activation which commenced after 2 min of clearing.
Volumetric (3D) FONT images were reconstructed from the acquired signals at each wavelength
using GPU-based implementation of a back-projection formula [34]. The signals were deconvolved with
the impulse response of the transducer array elements before reconstruction. In addition, a band-pass
filter with cut-off frequencies of 0.1 and 7.5 MHz was applied. Reconstruction of the volumetric image
data was performed on a grid of 150 × 150 × 100 voxels3 (equivalent to 15 × 15 × 10 mm3) to match
system’s spatial resolution. An example reconstruction for the data acquired before perfusion started
is seen in Figure 1b.
3. Results
3.1. Blood Clearing Procedure
Figure 2a shows the FONT images (maximum intensity projections (MIPs) along the top and
lateral directions) acquired at 488 nm and 650 nm excitation wavelengths at different instants after
starting the perfusion procedure. The background absorption signal was clearly reduced when the
blood was substituted by ACSF, thus enhancing the effective light penetration and the corresponding
imaging depth. Prior to perfusion, signals at the 488 nm wavelength were detected at a maximal depth
of ~1 mm. Prior to perfusion, the strongest signals, corresponding to blood at both wavelengths, were
detected in vessels such as the superior sagittal sinus (SSS), the pial branches of the anterior cerebral
artery and the transverse sinuses (Trs). Following 60 s of intracardiac perfusion, all vessels except for
the rostral confluence of sinuses were observed to become mostly free of blood. The relative signal
changes as a function of time are plotted in Figure 2b for selected voxels in the volumetric FONT
images (marked with the corresponding colors in Figure 2a). The signal was reduced by ~98% for a
cortical blood vessel (red profiles), indicating high efficiency of the clearing procedure. A similar effect
was observed in another cortical area outside the major vessels (blue profiles). In this case, the FONT
signal dropped by ~95% at 650 nm while declining to 20% from its original levels at 488 nm, possibly
indicating the presence of significant GCaMP protein contribution. The green curves correspond to a
deeper area (~1.5 mm) in the brain. In this case, no significant changes in the FONT signal intensity at
650 nm were observed, while the signal at 488 nm clearly increased by ~150%. This is likely ascribed to
the GCaMP signal being enhanced due to a reduced optical attenuation after clearing.
The clearing process of a GCaMP6f mouse head as seen under wide-field fluorescence imaging
is shown in Figure 3a. Vessels such as the SSS and anterior cerebral artery (Acer) can be identified
before commencement of the perfusion process but disappear after 60 s of clearing with ACSF.
Further perfusion did not result in a signal increase, indicating that most blood is removed after
60 s if the procedure is performed correctly. Due to the limitation of planar fluorescence imaging
to pure 2D (surface-weighted) visualization and intense scattering of light in the brain, the images
are diffuse in their appearance. As blood is being removed, the overall recorded fluorescence signal
intensity of the mouse brain increased by 80–140% (Figure 3b), although discrimination of signals
originating from different depths was not possible. Unlike fluorescence recordings, FONT was capable
of imaging the mouse brain through skin and skull at a high spatial resolution and in 3D, enabling
signal characterization at different depths. As shown in Figure 2a, the background signal could
significantly be reduced after ACSF perfusion. More details on the discernible structures in the
volumetric FONT images are shown in the transverse and coronal cross-sections displayed in Figure 3c
along with the corresponding reference images taken from the Allen Mouse Common coordinate
Framework [35]. Anatomical structures including both cortical hemispheres and the hippocampus
could be distinguished after 60 s of ACSF perfusion. Overall, the removal of blood allowed for signal
detection at least up to 3 mm depth.
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The recorded EEG signals along with their power spectrum representing the frequency distribution 
of the brain activity are shown in Figure 4a. During the in vivo recording prior to the start of perfu-
sion, the most prominent signal variations were detected at low frequencies (3–10 Hz), which are 
analogous to those expected in the anesthetized brain state. After initiation of the perfusion, EEG 
signal amplitudes decreased, forming a new baseline which was recorded for 10 min. Neuronal 
stimulation was then induced through PTZ (100 mg/ml) application via an injection port connected 
to the ACSF delivering tube. A visible increase in EEG signal amplitude was detected and higher 
frequency signals associated with seizure activity in the range of 10–25 Hz appeared in the frequen-
Figure 3. (a) Planar wide-field fluorescence images of the blood clearing procedure in a GCaMP6f-labeled
mouse. F: fluorescence; SSS: sup rior sagittal sinus; Acer: anteri r cerebral artery (b) Time-traces
of the normalized fluorescence data are shown fr m region of interest indicated in panel A. While
overall signal int nsity increases as blood is remov d, planar fluo sce ce cannot distinguish s gnal
changes at different depths. (c) Transverse orthoslice from the volumetric FONT re ordings at 1.5 mm
depth is shown along with the corresponding coronal slice during perfusion. Aft r 60 s, the median
FONT signal increases, enabling the identification of several brai structures. L/RC: left/right cortex;
h: hippocampus; Cb: Cerebellum. Red lines indicate slice positions for both iews. Reference images
are tak n from the Allen Mouse Common coordinate Framework [35].
3.2. Validation of Brain Viability
To assess cha ges in neuronal activity and evaluate the brain’s viability and functionality following
blood replacement with oxygenated ACSF, EEG-recordings were performed on GCaMP6f mice. For this,
EEG-data was acquired from the cortex of anesthetized animals that were subsequently perfused
and later administered the neuro-stimulating drug Pentylenetetrazol (PTZ) by adding it to the ACSF
mixture via stopcock, thus inducing fast seizure-like activity in the brain [36]. The recorded EEG
signals along with their power spectrum representing the frequency distribution of the brain activity
are shown in Figure 4a. During the in vivo recording prior to the start of perfusion, the most prominent
signal variations were detected at low frequencies (3–10 Hz), which are analogous to those expected
in the anesthetized brain state. After initiation of the perfusion, EEG signal amplitudes decreased,
forming a new baseline which was recorded for 10 min. Neuronal stimulation was then induced
through PTZ (100 mg/mL) application via an injection port connected to the ACSF delivering tube.
A visible increase in EEG signal amplitude was detected and higher frequency signals associated with
seizure activity in the range of 10–25 Hz appeared in the frequency distribution. Across-the-board,
activity in the EEG data lasted for up to 45 min after the beginning of perfusion.
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Figure 5). Signal increases were only detected in the data acquired at 488 nm, while no significant 
changes could be observed in the data collected at 650 nm (data not shown). Single voxel analysis of 
cortical areas at 0.3 mm depth revealed signal increase of up to 50% at 488 nm compared to baseline 
levels prior to the start of injection (Figure 4a, left), while analysis of cortex and hippocampal areas 
at 1.5 mm depth has rendered increases up to 40% (Figure 4a, right). Sham injections of PBS into the 
ACSF flow were performed on GCaMP6f mice as a negative control (n = 2, Figure 4b) and did not 
induce any significant changes in the FONT signals. A more detailed visualization of the activated 
areas is provided in the transverse cross-sections for different depths displayed in Figure 4c. It is 
Figure 4. Validation of perfused brain viability with electroencephalography (EEG) and planar wide-field
fluorescence recordings. (a) EEG signals recorded in a GCaMP6f mouse before and after cardiac perfusion.
The signal power spectra represent the frequency distribution of the brain activity. Following the
addition of Pentylenetetrazol (PTZ) to the perfusion solution, an increase in both signal amplitude and
its 10–20 Hz frequency components could be detected. (b) Temporal sequence of fluorescence-recorded
brain activation maps in response to PTZ injection at t = 0. (c) Background-subtracted and normalized
fluorescence signal traces whose position is indicated in panel B.
Additionally, wide-field fluorescence recordings were performed on GCaMP6f mice in order to
validate neuronal functionality and responsiveness to PTZ stimulation during intracardiac perfusion
(Figure 4b,c). As negative controls, three GCaMP6f-expressing mice were injected with PBS instead.
The PTZ injection (100 mg/ml) through the tube delivering oxygenized ACSF resulted in a whole-brain
response (Figure 4b) and led to an increase of fluorescence signals of up to 20% over baseline levels
(Figure 4c). No significant changes in fluorescence intensity were detected in the PBS co trols
(data not shown).
3.3. Volumetric FONT Imaging of Stimul ted Calcium Activity
Following confirmation that the perfused mouse model was responsive to PTZ stimulation, FONT
was used to observe three-dimensional multispectral (488 nm and 650 nm excitation) calcium changes
and thus PTZ induced neuronal activation in GCaMP6f-expressing mouse brains (n = 3, Figure 5).
Signal increases were only detected in the data acquired at 488 nm, while no significant changes could
be observed in the data collected at 650 nm (data not shown). Single voxel analysis of cortical areas
at 0.3 mm depth revealed signal increase of up to 50% at 488 nm compared to baseline levels prior
to the start of injection (Figure 4a, left), while analysis of cortex and hippocampal areas at 1.5 mm
depth has rendered increases up to 40% (Figure 4a, right). Sham injections of PBS into the ACSF
flow were performed on GCaMP6f mice as a negative control (n = 2, Figure 4b) and did not induce
any significant changes in the FONT signals. A more detailed visualization of the activated areas is
provided in the transverse cross-sections for different depths displayed in Figure 4c. It is shown that
signal changes were detected at a depth of up to 3 mm following stimulation, while in areas located at a
depth of 4.5 mm and lacking genetically induced GCaMP expression no signal changes were observed
at 488 nm.
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4. Discussion and Conclusions 
Optoacoustic imaging has recently been demonstrated as a valid method for functional, non-
invasive observations of transient calcium fluxes in cortical structures of zebrafish [21] and an in-
Figure 5. Volumetric FONT imaging of neuronal activation in the perfused GCaMP mouse model at
488 nm. (a) Time-traces of the normalized FONT data along with moving averages over 10 image
frames are shown from individual voxels at 0.3 and 1.5 mm brain depth—positions are indicated in
panel C. (b) Normalized, averaged FONT traces at 0.3 mm depth following a PBS injection (control
experiment) exhibit no signal changes. (c) Temporal progression of the relative FONT signal changes in
three representative slices located at depths of 0.3, 1.5, 3 and 4.5 mm in a GCaMP6f-expressing mouse
brain. PTZ injection was performed at t = 0.
. l si s
imaging has r cently been demonstrated as a valid method for functi al,
non-invasive observations of transient calcium fluxes n cortical structures of zebrafish [21] and
an in-vivo mouse model expressing GCaMP6-type indicators [28]. By combining an effective field of
view covering the entire mouse brain with spatio-temporal scales not achievable by other neuroimaging
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modalities and deeper tissue penetration than conventional optical approaches, FONT has proven to be
a viable new tool for the observation of whole-brain neuronal network interactions across long distances.
However, strong absorption of light by hemoglobin at the GCaMP6 excitation wavelength of 488 nm
makes direct visualization of calcium activity through GCaMP6 signal changes in deeper brain regions
highly challenging in-vivo. The development of near-infrared calcium indicators with absorption
peaks above 650 nm, such as NIR-GECO1 [37], is underway, and adapting them to OA imaging would
allow even higher depth penetration due to a significantly lower blood absorption background at
these wavelengths. Unfortunately, this indicator will require further rounds of improvement before its
performance in OA mode is comparable to GCaMP.
A possible solution to acquiring FONT signals from subcortical brain areas with existing calcium
indicators is the use of a blood-free brain model. In a previous study, we have established a functional
blood-free excised brain preparation superfused with oxygenated ACSF [28], for which in-vivo-like
neuronal functionality could be observed during ~30 min after brain extraction. However, the brain
extraction method has major caveats. The reliance on passive diffusion complicates delivery of oxygen
and nutrients to deep brain regions past the 30 min mark, increasing the chance of hypoxia and cell
death that adversely affects the model. In addition, the complexity of the preparation raised the chance
of failure and the absence of anatomical references (e.g., Bregma) made targeting specific regions for
stimulation at specific depths more challenging. Moreover, small volumes of highly concentrated PTZ
had to be injected directly into the brain and depending on the glass micro-capillary position some of
its contents would leak into the superfusion chamber, adding more variability to the experimental
results. Blood-free studies in larger rodents, such as isolated guinea-pig brains [38] and isolated rat
brains [39], utilized perfusion through the cortical vasculature to mimic in vivo conditions in the
entire brain and keep it responsive to electric stimuli for up to 8 h post excision. Such approaches
are however surgically challenging when applied to the much smaller mouse model, for which the
suggested intracardiac perfusion was found to be suitable.
The presented results showcase a strategy for eliminating the highly absorbing blood background
from a functional murine whole brain model, enabling direct tracking of calcium dynamics associated
with neuronal activity at depths previously inaccessible with FONT and extending the time window in
which a response to stimuli can be triggered. Furthermore, it is now possible to observe and evaluate
the transition between an in-vivo brain model (prior to perfusion) and a blood free in-situ preparation
(after perfusion), providing a platform to further explore the relation between epifluorescence and
optoacoustic signals for GCaMP6 indicators. A simpler, quicker surgical procedure in comparison
to the isolated brain model [40] increased the success rate of performed experiments, thus reducing
the number of animals required for the study. By utilizing the vascular system we were able to fully
replace the blood with ACSF, and thereby double the maximum depth from which GCaMP6f signals
could be collected. Furthermore, the whole brain could be efficiently supplied with nutrients and
oxygen for more than 30 min following blood clearance, which in combination with physiological
pressure, temperature and glucose levels should allow for closer mimicry of in-vivo conditions. Brain
viability was validated by EEG recordings indicating the presence of neuronal activity for at least
45 min following the start of perfusion, while the stimulus response to PTZ injection was observed
in EEG, planar fluorescence, and FONT recordings. The FONT imaging enabled a clear detection of
calcium fluxes as true high-resolution 3D-information not affected by intense light scattering in the
brain, while epi-fluorescence recordings failed to provide high resolution maps of depth-resolved
calcium dynamics. Since the total duration of the stimulation experiments including the full removal
of blood was below 10 min, the data acquired can be attributed to in-vivo-like neuronal functionality.
The presented model is not without limitations and multiple aspects can be further improved.
Simultaneous acquisition of epifluorescence and optoacoustic data at sufficient depth through the use of
a fibroscope [41] was not achievable at the time of the study, complicating direct comparisons of specific
regions in both modes beyond a proof-of-concept viewpoint between animals. This is now becoming
possible thanks to recent advancements in fibroscope design. In addition, due to the use of very high
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anesthesia doses and general setup layout, common stimulation paradigms such as paw or whisker
stimulation could not be applied to our mouse model, necessitating the use of a pharmacological
compound to induce neuronal activity. Excitation with PTZ invoked robust, albeit widespread changes
in calcium dynamics across large areas of the brain. To adapt this preparation for use in functional
mapping of network connectivity, the use of drugs targeting specific neuronal populations must be
explored in future studies. However, this methodology is not limited to pharmacological stimulation
paradigms. The use of widely tunable lasers with 0.1-1 kHz repetition rates for excitation in our
technology could in theory allow the interrogation of specific circuits through optogenetics [42], while
the spherical matrix transducer array used for data acquisition could be modified for concurrent use
with transcranial ultrasound stimulation to excite small volumes of brain tissue [43,44]. Another caveat
is the mesoscopic resolution of 150 µm which can be scaled down to ~35 µm using high-frequency
matrix array probes at the cost of a smaller FOV [45]. The use of GCaMP mouse models with sparse
expression [46] in areas of interest such as the hippocampus or specific cortex layers could theoretically
enable access to normal and dysregulated neuronal network interactions at a whole-brain level within
previously homogeneous non-sparse cell populations with high temporal resolution. Yet the most
glaring issue is the limited viability of the preparation (45 min) and the impossibility of longitudinal
studies due to the invasive and final cardiac perfusion procedure. Survivability of the brain after
blood clearing could be prolonged through the improvement of the blood replacement mixture by
adjusting ion concentrations, inclusion of cytoprotective agents [47] and the addition of a dedicated,
perfluorocarbon-based oxygen carrier [48] lacking strong absorption in OA mode. Furthermore,
adaptation of a “bloodless” mouse model akin to existing rat protocols [49,50] could allow long-term
studies over the span of days or weeks until animals replace missing hematologic components, but
great care must be taken to ensure adherence to current ethics regulations and animal welfare protocols.
In conclusion, we have developed a novel intracardiac perfusion in situ brain model to
optoacoustically monitor deep brain calcium dynamics under blood-free conditions at unprecedented
depths and spatio-temporal resolutions not attainable with other optical microscopy modalities.
The model provides a framework to further explore the relation between fluorescence and optoacoustic
signals for existing or emerging calcium/voltage indicators. It can be further adapted for the functional
observation and/or mapping of network connectivity between specific cortical and subcortical structures
in the murine model.
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